Analysis of Liquidity Ratios
Quarterly Data
Liquidity ratios measure the company ability to meet its short-term obligations.
Liquidity Ratios (Summary)
Express Scripts Holding Co., liquidity ratios (quarterly data)
Based on: 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31).
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Express Scripts Holding Co. current ratio improved from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Express Scripts Holding Co. quick ratio improved from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Express Scripts Holding Co. cash ratio improved from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |
Current Ratio
Express Scripts Holding Co., current ratio calculation (quarterly data)
| Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||
| Current assets | 14,352,200) | 13,170,100) | 11,474,800) | 11,957,100) | 12,679,000) | 11,636,800) | 12,089,200) | 12,363,400) | 11,123,000) | 10,614,500) | 10,399,800) | 12,059,500) | 10,274,400) | 9,637,700) | 9,171,500) | 10,568,100) | 9,704,700) | 10,452,400) | 8,134,400) | 8,491,400) | 9,224,200) | 8,302,800) | 8,707,900) | |||||||
| Current liabilities | 18,691,400) | 18,586,700) | 16,723,100) | 17,846,400) | 17,356,800) | 16,779,300) | 17,041,700) | 16,428,100) | 15,978,500) | 19,136,500) | 17,236,900) | 17,155,300) | 16,013,800) | 15,868,800) | 14,900,200) | 17,016,900) | 15,922,500) | 15,984,400) | 13,574,900) | 13,235,300) | 11,226,200) | 10,618,300) | 11,524,100) | |||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||||
| Current ratio1 | 0.77 | 0.71 | 0.69 | 0.67 | 0.73 | 0.69 | 0.71 | 0.75 | 0.70 | 0.55 | 0.60 | 0.70 | 0.64 | 0.61 | 0.62 | 0.62 | 0.61 | 0.65 | 0.60 | 0.64 | 0.82 | 0.78 | 0.76 | |||||||
| Benchmarks | ||||||||||||||||||||||||||||||
| Current Ratio, Competitors2 | ||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 2.43 | 2.40 | 1.64 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Shockwave Medical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31).
1 Q3 2018 Calculation
Current ratio = Current assets ÷ Current liabilities
= 14,352,200 ÷ 18,691,400 = 0.77
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Current ratio | A liquidity ratio calculated as current assets divided by current liabilities. | Express Scripts Holding Co. current ratio improved from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |
Quick Ratio
Express Scripts Holding Co., quick ratio calculation (quarterly data)
| Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||
| Cash and cash equivalents | 3,705,700) | 2,942,300) | 2,317,600) | 2,309,600) | 3,395,900) | 2,352,500) | 3,163,800) | 3,077,200) | 2,304,700) | 1,324,400) | 1,771,100) | 3,186,300) | 438,200) | 721,000) | 905,800) | 1,832,600) | 834,800) | 2,835,200) | 1,850,400) | 1,991,400) | 1,722,300) | 1,342,200) | 1,990,000) | |||||||
| Receivables, net | 7,824,100) | 7,338,100) | 6,793,600) | 7,056,300) | 6,871,500) | 7,067,500) | 6,936,100) | 7,062,100) | 6,967,000) | 7,373,600) | 6,758,400) | 6,721,300) | 7,391,100) | 6,494,500) | 5,819,400) | 5,979,800) | 6,384,500) | 5,178,200) | 3,907,300) | 4,022,900) | 5,112,400) | 4,552,800) | 4,294,100) | |||||||
| Total quick assets | 11,529,800) | 10,280,400) | 9,111,200) | 9,365,900) | 10,267,400) | 9,420,000) | 10,099,900) | 10,139,300) | 9,271,700) | 8,698,000) | 8,529,500) | 9,907,600) | 7,829,300) | 7,215,500) | 6,725,200) | 7,812,400) | 7,219,300) | 8,013,400) | 5,757,700) | 6,014,300) | 6,834,700) | 5,895,000) | 6,284,100) | |||||||
| Current liabilities | 18,691,400) | 18,586,700) | 16,723,100) | 17,846,400) | 17,356,800) | 16,779,300) | 17,041,700) | 16,428,100) | 15,978,500) | 19,136,500) | 17,236,900) | 17,155,300) | 16,013,800) | 15,868,800) | 14,900,200) | 17,016,900) | 15,922,500) | 15,984,400) | 13,574,900) | 13,235,300) | 11,226,200) | 10,618,300) | 11,524,100) | |||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||||
| Quick ratio1 | 0.62 | 0.55 | 0.54 | 0.52 | 0.59 | 0.56 | 0.59 | 0.62 | 0.58 | 0.45 | 0.49 | 0.58 | 0.49 | 0.45 | 0.45 | 0.46 | 0.45 | 0.50 | 0.42 | 0.45 | 0.61 | 0.56 | 0.55 | |||||||
| Benchmarks | ||||||||||||||||||||||||||||||
| Quick Ratio, Competitors2 | ||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 1.85 | 1.84 | 1.25 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Shockwave Medical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31).
1 Q3 2018 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 11,529,800 ÷ 18,691,400 = 0.62
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Quick ratio | A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. | Express Scripts Holding Co. quick ratio improved from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |
Cash Ratio
Express Scripts Holding Co., cash ratio calculation (quarterly data)
| Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Jun 30, 2013 | Mar 31, 2013 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||||||
| Cash and cash equivalents | 3,705,700) | 2,942,300) | 2,317,600) | 2,309,600) | 3,395,900) | 2,352,500) | 3,163,800) | 3,077,200) | 2,304,700) | 1,324,400) | 1,771,100) | 3,186,300) | 438,200) | 721,000) | 905,800) | 1,832,600) | 834,800) | 2,835,200) | 1,850,400) | 1,991,400) | 1,722,300) | 1,342,200) | 1,990,000) | |||||||
| Total cash assets | 3,705,700) | 2,942,300) | 2,317,600) | 2,309,600) | 3,395,900) | 2,352,500) | 3,163,800) | 3,077,200) | 2,304,700) | 1,324,400) | 1,771,100) | 3,186,300) | 438,200) | 721,000) | 905,800) | 1,832,600) | 834,800) | 2,835,200) | 1,850,400) | 1,991,400) | 1,722,300) | 1,342,200) | 1,990,000) | |||||||
| Current liabilities | 18,691,400) | 18,586,700) | 16,723,100) | 17,846,400) | 17,356,800) | 16,779,300) | 17,041,700) | 16,428,100) | 15,978,500) | 19,136,500) | 17,236,900) | 17,155,300) | 16,013,800) | 15,868,800) | 14,900,200) | 17,016,900) | 15,922,500) | 15,984,400) | 13,574,900) | 13,235,300) | 11,226,200) | 10,618,300) | 11,524,100) | |||||||
| Liquidity Ratio | ||||||||||||||||||||||||||||||
| Cash ratio1 | 0.20 | 0.16 | 0.14 | 0.13 | 0.20 | 0.14 | 0.19 | 0.19 | 0.14 | 0.07 | 0.10 | 0.19 | 0.03 | 0.05 | 0.06 | 0.11 | 0.05 | 0.18 | 0.14 | 0.15 | 0.15 | 0.13 | 0.17 | |||||||
| Benchmarks | ||||||||||||||||||||||||||||||
| Cash Ratio, Competitors2 | ||||||||||||||||||||||||||||||
| Abbott Laboratories | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Cigna Group | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| CVS Health Corp. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Elevance Health Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Humana Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Intuitive Surgical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Medtronic PLC | 1.32 | 1.29 | 0.86 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| Shockwave Medical Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
| UnitedHealth Group Inc. | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |||||||
Based on: 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31).
1 Q3 2018 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 3,705,700 ÷ 18,691,400 = 0.20
2 Click competitor name to see calculations.
| Liquidity ratio | Description | The company |
|---|---|---|
| Cash ratio | A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. | Express Scripts Holding Co. cash ratio improved from Q1 2018 to Q2 2018 and from Q2 2018 to Q3 2018. |